Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
AbbVie Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
ABBV
New York
2834
https://www.abbvie.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for AbbVie Inc
The Top Healthcare Stocks to Buy With $100
- Mar 31st, 2023 2:00 pm
This Blockbuster Drug's Latest News Could Be Another Home Run for AbbVie
- Mar 31st, 2023 12:50 pm
Starter Stock Portfolio: 15 Safe Stocks To Buy
- Mar 30th, 2023 3:02 pm
2 High-Yielding Dividend Investments to Buy for the Long Haul
- Mar 30th, 2023 11:45 am
12 Most Promising Healthcare Stocks According to Analysts
- Mar 29th, 2023 8:40 pm
Better Growth Stock: Vertex Pharmaceuticals vs. AbbVie
- Mar 29th, 2023 6:00 pm
Allergan Aesthetics* to showcase 360° approach to clinical practice, aesthetic products, and patients with expert-led symposia at AMWC 2023
- Mar 29th, 2023 1:00 pm
Better Growth Stock: AbbVie vs. Pfizer
- Mar 29th, 2023 11:30 am
AbbVie Walks Away From CytomX Partnership, But Garnering Attention Of Big Pharma Partners
- Mar 28th, 2023 5:35 pm
2 Relatively Safe Dividend Stocks You Won't Regret Owning
- Mar 28th, 2023 2:07 pm
This Is the Best Dividend ETF You Can Buy
- Mar 28th, 2023 12:13 pm
CIBC introduces additional Canadian Depositary Receipts ("CDRs")
- Mar 28th, 2023 12:00 pm
AbbVie (ABBV) Stock Sinks As Market Gains: What You Should Know
- Mar 27th, 2023 9:45 pm
Here's Why AbbVie (NYSE:ABBV) Can Manage Its Debt Responsibly
- Mar 27th, 2023 12:00 pm
The Zacks Analyst Blog Highlights Sanofi, Regeneron, AbbVie, Roche and Eli Lilly
- Mar 27th, 2023 11:41 am
Who Are Pfizer's (PFE) Main Competitors?
- Mar 25th, 2023 5:38 pm
Better Buy: AbbVie vs. Johnson & Johnson
- Mar 25th, 2023 9:30 am
Pharma Stock Roundup: SNY's COPD Study Meets Goal, ABBV Parkinson's Drug Gets CRL
- Mar 24th, 2023 1:04 pm
The price of Humira's biosimilars can uncloak the secret villain of US drug pricing
- Mar 23rd, 2023 2:30 pm
2 High-Yield Dividend Stocks You Won't Regret Buying Right Now
- Mar 23rd, 2023 2:00 pm
Scroll